| Literature DB >> 30622337 |
Ditte Marie Brix1, Siri Amanda Tvingsholm1, Malene Bredahl Hansen1, Knut Bundgaard Clemmensen1, Tiina Ohman2, Valentina Siino3, Matteo Lambrughi4, Klaus Hansen5, Pietri Puustinen1, Irina Gromova6, Peter James7, Elena Papaleo4, Markku Varjosalo2, José Moreira8, Marja Jäättelä9, Tuula Kallunki10,11.
Abstract
HER2/ErbB2 activation turns on transcriptional processes that induce local invasion and lead to systemic metastasis. The early transcriptional changes needed for ErbB2-induced invasion are poorly understood. Here, we link ErbB2 activation to invasion via ErbB2-induced, SUMO-directed phosphorylation of a single serine residue, S27, of the transcription factor myeloid zinc finger-1 (MZF1). Utilizing an antibody against MZF1-pS27, we show that the phosphorylation of S27 correlates significantly (p < 0.0001) with high-level expression of ErbB2 in primary invasive breast tumors. Phosphorylation of MZF1-S27 is an early response to ErbB2 activation and results in increased transcriptional activity of MZF1. It is needed for the ErbB2-induced expression of MZF1 target genes CTSB and PRKCA, and invasion of single-cells from ErbB2-expressing breast cancer spheroids. The phosphorylation of MZF1-S27 is preceded by poly-SUMOylation of K23, which can make S27 accessible to efficient phosphorylation by PAK4. Based on our results, we suggest for an activation mechanism where phosphorylation of MZF1-S27 triggers MZF1 dissociation from its transcriptional repressors such as the CCCTC-binding factor (CTCF). Our findings increase understanding of the regulation of invasive signaling in breast cancer by uncovering a detailed biological mechanism of how ErbB2 activation can rapidly lead to its invasion-promoting target gene expression and invasion.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30622337 PMCID: PMC6525100 DOI: 10.1038/s41388-018-0653-x
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867